Loading company…
Novagali Pharma develops ophthalmic products and treatments for eye conditions.
Novagali Pharma develops eye care products and formulations for treating ocular conditions. Founded in 2000, it is based in France and completed an IPO in July 2010, raising EUR 22.00 mn. Santen Pharmaceutical acquired the company in October 2011.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in